OmniAb, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACET
|
Adicet Bio, Inc. | $1.41 | $110.93 M | -0.46 | 143 | $0 |
 BCAB
|
BioAtla, Inc. | $1.77 | $73.14 M | -0.61 | 65 | $0 |
 CGEM
|
Cullinan Oncology, Inc. | $16.72 | $1.29 B | -7.16 | 85 | $0 |
 ERAS
|
Erasca, Inc. | $2.57 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $27.51 | $1.65 B | -11.47 | 97 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $5.27 | $243.38 M | -1.59 | 129 | $0 |
 IDYA
|
IDEAYA Biosciences, Inc. | $31.06 | $2.88 B | -19 | 124 | $23.39 M |
 IKNA
|
Ikena Oncology, Inc. | $1.70 | $84.45 M | -1.11 | 18 | $9.16 M |
 IPSC
|
Century Therapeutics, Inc. | $1.61 | $244.54 M | -1.32 | 152 | $2.24 M |
 ITOS
|
iTeos Therapeutics, Inc. | $9.98 | $603.25 M | -4.42 | 157 | $12.60 M |
 KROS
|
Keros Therapeutics, Inc. | $59.31 | $1.76 B | -9.45 | 149 | $151,000 |
 LEGN
|
Legend Biotech Corporation | $47.08 | $8.31 B | -17.66 | 2200 | $285.14 M |
 NGM
|
NGM Biopharmaceuticals, Inc. | $1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
 OLMA
|
Olema Pharmaceuticals, Inc. | $12.14 | $734.41 M | -6.56 | 80 | $0 |
 PASG
|
Passage Bio, Inc. | $0.70 | $73.04 M | -0.77 | 58 | $0 |
 PMVP
|
PMV Pharmaceuticals, Inc. | $1.50 | $85.40 M | -1.26 | 63 | $0 |
 TALS
|
Talaris Therapeutics, Inc. | $2.72 | $116.44 M | -1.56 | 84 | $0 |
 VOR
|
Vor Biopharma Inc. | $0.66 | $83.62 M | -0.69 | 168 | $0 |
 VRNA
|
Verona Pharma plc | $28.92 | $983.52 M | -15.16 | 79 | $0 |